Arcus Biosciences

This #WorldPancreaticCancerDay, we confront a stark reality: progress in #pancreaticcancer research is not moving fast enough. This disease is one of the most aggressive cancers, and too many lives are impacted by the limited treatment options. We refuse to accept this and are dedicated to accelerating research and developing therapies that can make a difference. Learn more about how we are designing combination therapies in our relentless pursuit of cures for cancer: https://bit.ly/4hQ3dyd #PancreaticCancerAwarenessMonth

Where do you see yourself in five or ten years? Jonathan always had a clear vision. He set ambitious goals and worked tirelessly to achieve them. He challenged himself physically, built an impressive career as a Navy hospital corpsman, and raised three children with his wife. But after his diagnosis of #stomachcancer, he began to question where his new path would lead him. Learn more about Jonathan’s story and view the rest of the #PortrAItsofCancer gallery: https://bit.ly/4eCl3BV #StomachCancerAwarenessMonth Debbie's Dream Foundation: Curing Stomach Cancer

It’s always a spookily spectacular Halloween here with the Arcus Team! Check out some of the winners from our 4th annual Spooktacular Contest, including the Biophysics “mad scientists,” with real-life foam reactions ?? ?? a special appearance from a furrier than usual Bob Ross ?? ?? and plenty of creepy clowns ??

We are honored to have participated in LUNGevity Foundation's annual Breathe Deep Together Walk for #LungCancerAwarenessMonth taking place in New York, DC and Boston. Though Team Arcus spans across the United States, we are brought together by the urgent need to pursue cures for cancer. Together, we can make a difference.

Team Arcus was proud to sponsor and attend Lung Cancer Research Foundation's Free to Breathe Walk in Chicago in recognition of #LungCancerAwarenessMonth. Connecting with our community is an inspiring reminder of why we come to work every day and do what we do for those living with cancer.

We’re reporting our third-quarter financial results and an update on our clinical-stage pipeline. https://bit.ly/4fco90T

Today we announced the first overall survival results for the combination of investigational molecules domvanalimab and zimberelimab in #lungcancer. These data will be presented in a late-breaking poster at the Society for Immunotherapy of Cancer (SITC) Annual Meeting this week. Read the results here: https://bit.ly/4hOauPl #SITC24

When Doug's wife was diagnosed with #lungcancer, his entire world changed. However rather than focusing on the unknown, he chooses to celebrate every moment, whether it's a game of basketball with his grandkids or a walk with his wife. Doug finds joy in each day he has with his family. Learn more about his story and view the rest of the digital gallery: https://lnkd.in/g2ttnjVf #PortrAItsofCancer #LungCancerAwarenessMonth LUNGevity Foundation

The first overall survival results to be reported for the combination of domvanalimab and zimberelimab in #lungcancer will be presented in a late-breaking poster at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in November. Read more about this news and other data we’ll be presenting: https://bit.ly/3Uw87X5 #SITC24

Last week, we were at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics presenting our latest #cancer research on our HIF-2a inhibitor and AXL inhibitor. Access our presentations here: https://bit.ly/3WmLBzq #ENASymp24